Sana biotechnology announces publication in new england journal of medicine of groundbreaking clinical data from transplantation without immunosuppression of hypoimmune-modified, insulin-producing islet cells in patient with type 1 diabetes

Data demonstrate that sana's hypoimmune (hip)-modified pancreatic islet cells, transplanted with no immunosuppression, persist and function over time in patient with type 1 diabetes

SANA Ratings Summary

SANA Quant Ranking